Patent classifications
C
C07
C07C
59/00
C07C59/185
C07C59/225
C07C59/225
CO-CRYSTAL OF AFICAMTEN, AND PREPARATION METHOD THEREFOR AND USE THEREOF
20250382286
·
2025-12-18
·
·
The present disclosure relates to co-crystal of Aficamten and tartaric acid, and preparation methods thereof, pharmaceutical compositions containing the crystalline forms, and uses of the co-crystal for preparing cardiac myosin inhibitor and drugs for treating hypertrophic cardiomyopathy.
Salts of a compound and the crystalline forms thereof
The present invention relates to the salts of a compound and the crystalline forms thereof. More specifically, the present invention belongs to the pharmaceutical field, and provides the pharmaceutically acceptable salts of the compound.